Skip to main content
AIMD logo
AIMD
(NASDAQ)
Ainos, Inc.
$1.85-- (--)
Loading... - Market loading

Ainos (AIMD) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Ainos, Inc.
AIMDNasdaq Stock MarketTechnologyScientific & Technical Instruments

About Ainos

Ainos, Inc., a dual-platform company, focusing artificial intelligence–based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women’s health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone281 898 6586
Address
3050 Post Oak Boulevard, Suite 510-T80 Houston, Texas 77056 United States

Corporate Identifiers

CIK0001014763
CUSIP00902F402
ISINUS00902F4028
EIN75-1974352
SIC3577

Leadership Team & Key Executives

Chun-Hsien Tsai
Chief Executive Officer, President and Chairman of the Board
Hsin-Liang Lee
Chief Financial Officer
Chih-Heng Lu
Director of Corporate Developoment